Search results

Receiving grants from the Swedish Research Council is viewed as a quality mark and one of the critical steps for young scientists to establish an independent research group. Recently, five of MultiPark’s research leaders were awarded funding for their projects. This year’s support from the Swedish Research Council encouraged MultiPark’s ambition to be a multidisciplinary research area. Projects ra

https://www.multipark.lu.se/article/multipark-scientists-granted-support-swedish-research-council - 2026-06-25

Malin Parmar, professor of cellular neuroscience leading one of MultiPark's research groups, along with three researchers in Italy and Denmark, has been awarded the prestigious ERC Synergy Grant worth EUR 10 million. The four researchers aim to develop custom-made neurons from stem cells for cell therapies to treat Parkinson’s or Huntington’s disease. “We want to develop a completely new concept i

https://www.multipark.lu.se/article/erc-synergy-grant-development-custom-made-stem-cell-therapies-neurodegenerative-disorders - 2026-06-25

Patients with frontotemporal dementia often lack the ability to empathize. A study at Lund University and Karolinska Institutet has now shown that these patients do not show the same brain activity as healthy individuals when they witness the pain of others, a finding that it is hoped will increase understanding of this specific dementia disease. This is an important piece of the puzzle now fallin

https://www.multipark.lu.se/article/new-study-shows-how-dementia-affects-brains-ability-empathise - 2026-06-25

A team of international researchers led by Professor Johan Jakobsson at Lund University has secured a 52 million SEK grant from the Aligning Science Across Parkinson’s (ASAP) initiative, in partnership with the Michael J Fox Foundation to investigate how mobile genetic elements —commonly referred to as "jumping genes"—contribute to neuroinflammation and the progression of Parkinson’s disease. Jump

https://www.multipark.lu.se/article/52-million-sek-goes-uncovering-genetic-drivers-parkinsons-disease - 2026-06-25

Dear colleagues and collaborators,As we approach the end of 2024, I believe that we can look back with pride on the many things that we have achieved together this year. We would like to thank all of you for your vital contributions to our research environment, encompassing diverse roles and capacities. Next year is poised to be a particularly eventful year for MultiPark. On December 12, the Swedi

https://www.multipark.lu.se/article/seasons-greetings-multipark - 2026-06-25

Dear colleagues and collaborators,Welcome to a new year with MultiPark!Our Management group has now resumed its activities at full pace, and we are happy to share some fresh information as follows:(i) The dates for this year´s meetings of the MultiPark Board and Steering group have been set and posted under this link https://www.multipark.lu.se/about-multipark/management. We welcome Oxana Klementi

https://www.multipark.lu.se/article/kicking-year-packed-program-ahead - 2026-06-25

Don't miss the latest episode of MultiPark's podcast Meet our scientists. MultiPark's newest research group leader, Henrik Ahlenius, shares his expertise about stem cells in aging and neurodegenerative diseases. In this episode, Henrik explains the fascinating interplay between aging, neurodegenerative diseases and stem cells - critical areas of study that Henrik Ahlenius has passionately pursued

https://www.multipark.lu.se/article/meet-our-scientists-podcast-henrik-ahlenius-about-stem-cells-aging-and-neurodegeneration - 2026-06-25

This week marked the kickoff of MultiPark's Advanced Neuroscience Course. In this exclusive program, students from around the world unite to explore neuroscience and the complexities of neurodegenerative diseases. During the Advanced Neuroscience Course, students gain insights from leading researchers and get hands-on lab experience, working closely with labs that match their interests. The course

https://www.multipark.lu.se/article/advanced-neuroscience-course-future-neuroscientists - 2026-06-25

A study at Lund University reveals that traumatic brain injury alters the small vessels in the brain, resulting in an accumulation of amyloid beta — a hallmark of Alzheimer’s disease. The findings suggest that vascular dysfunction could be an early driver in neurodegenerative disorders rather than being caused by neuronal damage. The study is published in Acta Neuropathologica. An increased risk o

https://www.multipark.lu.se/article/cracking-alzheimers-code-how-brain-trauma-triggers-disease - 2026-06-25

This year, MultiPark has the pleasure of welcoming two new research groups. The Mackenzie Lab aims to decode the neurobiological underpinnings of emotion through experimental studies in animal models. Jacob Vogel’s team uses AI to analyze clinical data for improved understanding as well as patient-tailored diagnosis and care of neurodegenerative disease patients. Say hello to Åsa Mackenzie and Jac

https://www.multipark.lu.se/article/multipark-grows-new-research-groups - 2026-06-25

What role does an inflammatory protein have in disease development? Which neuronal circuits cause different symptoms? How may diabetes affect Parkinson’s disease? Can motor signs be identifies early in individuals at risk for the disease? And how should patients in very advanced disease stages be treated to maintain their quality of life? These questions may soon have answers thanks to several ong

https://www.multipark.lu.se/article/molecule-patient-six-promising-projects-advance-parkinsons-research - 2026-06-25

Researchers at Lund University and Washington University have identified a blood marker that reflects the amount of Alzheimer’s pathology in the brain. This discovery may play a key role in determining who is most likely to benefit from the new Alzheimer’s drugs. In brief:A newly discovered blood marker, MTBR-tau243, can reveal how much Alzheimer’s disease pathology is present in the brain. The hi

https://www.multipark.lu.se/article/new-reliable-blood-marker-reveals-extent-alzheimers-pathology-brain - 2026-06-25

A simpler method of analysing blood samples for Alzheimer’s disease has been tested in a large multicentre study, led by Lund University in Sweden. “This is a major step in bringing simple blood tests for Alzheimer’s disease into the healthcare system globally,” say the researchers behind the study. In brief:The blood-based marker (P-tau217) may start to change several years before the onset of Al

https://www.multipark.lu.se/article/more-opportunities-test-alzheimers-using-new-analytical-method - 2026-06-25

Meet our scientist Gesine Paul-Visse to learn what happens at the interface where the brain and the body meet: the blood-brain barrier. Here, a very specialized cell, the pericyte, protects the brain and responds strongly to disease. Gesine Paul-Visse leads Translational Neurology, one of MultiPark’s research groups. As both a neurologist and a researcher, she has focused on neurodegeneration for

https://www.multipark.lu.se/article/meet-our-scientists-podcast-gesine-paul-visse-about-brains-frontline - 2026-06-25

This article is over 5 years old, and the information may therefore be outdated. Today Ulf Dahlstrand nailed his doctoral thesis. Ulf will defend his thesis on March 20th. 

https://www.photoacoustics.lu.se/article/nailing-doctoral-thesis - 2026-06-25

This article is over 5 years old, and the information may therefore be outdated. On Friday March 20th, Ulf Dahlstrand successfully defended his doctoral thesis with the title "Novel Diagnostic Tools for Skin and Periorbital Cancer: Exploring Photoacoustic Imaging and Diffuse Reflectance Spectroscopy" The defense was held at the Eye Clinic in Lund with the faculty opponent associate professor Marce

https://www.photoacoustics.lu.se/article/ulf-dahlstrand-have-successfully-defended-his-phd - 2026-06-25

This article is over 5 years old, and the information may therefore be outdated. On Friday May 22nd, Linda Thorisdottir successfully defended his doctoral thesis with the title "Visual Screening of Amblyopia, new Techniques and Surgical Solutions for Strabismus."   The defense was held at the Eye Clinic in Lund with the local examination committee members and the supervisors present. The faculty o

https://www.photoacoustics.lu.se/article/linda-thorisdottir-has-successfully-defended-her-phd - 2026-06-25

This article is over 5 years old, and the information may therefore be outdated. On June 11th and 12th medial students Benjamin Sjögren and Yousef Hamid successfully presented their master thesis.Benjamin's thesis investigated non-invasive hyperspectral imaging in skin cancer diagnostics. Skin cancer is one of the most common types of cancer worldwide. In order to improve patient survival through

https://www.photoacoustics.lu.se/article/congratulations-benjamin-sjogren-and-yousef-hamid-who-successfully-presented-their-master-thesis - 2026-06-25

This article is over 5 years old, and the information may therefore be outdated. We welcome two new master thesis student this fall! Medical student Douglas Larsson Albèr will investigate spectral unmixing in photoacoustics for boarders demarkation of melanoma. Medical student Ivan Nikolic will investigate Spectral unmixing in photoacoustics for borders demarkation of non-melanoma skin cancer. The

https://www.photoacoustics.lu.se/article/we-welcome-new-master-students - 2026-06-25

This article is over 5 years old, and the information may therefore be outdated. Giant Cell ArthritisA new study is pblished where we present a detailed evaluation of the safety regarding visual function and patient tolerability in healthy subjects, and define the spectral signature in the healthy temporal artery. Photoacoustic imaging did not affect the best corrected visual acuity, colour vision

https://www.photoacoustics.lu.se/article/new-publications - 2026-06-25